Lumea, the leader in integrated digital pathology, & OptraSCAN, the top end-to-end digital pathology solution provider, announced a collaboration agreement. LEHI, UTAH, UNITED STATES, April 27, 2023 — Lumea, a…
Read More
At the medical center of the University of Medicine and Pharmacy in Ho Chi Minh City, patients are not screened for bladder cancer using urine cytology because the pathology department…
Welcome to our first podcast! Today, our guest pathologists Jonhan Ho, MD, and Swikrity U Baskota, MD, share their top three things they didn’t know about becoming an attending pathologist….
The Digital Diagnostic Summit and Lumea are pleased to announce the start of a new pathology podcast: Ask a Pathologist. This podcast is a place where experienced pathologists come together…
Digital pathology isn’t just a concept for tomorrow; it’s transforming practice today. Lumea is at the forefront of this shift, providing the tools and insights you need to confidently navigate…
Simple Summary The current need to reduce costs in research and diagnostic histopathology is fueling the development of new technologies. Tissue microarray (TMA) technology facilitates the simultaneous preparation of multiple…
